BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 10544084)

  • 1. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
    Lapenta C; Santini SM; Logozzi M; Spada M; Andreotti M; Di Pucchio T; Parlato S; Belardelli F
    J Exp Med; 2003 Jul; 198(2):361-7. PubMed ID: 12874266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
    Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice.
    Garaci E; Aquaro S; Lapenta C; Amendola A; Spada M; Covaceuszach S; Perno CF; Belardelli F
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8927-32. PubMed ID: 12853577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
    Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
    Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCID-hu mice: a model for studying disseminated HIV infection.
    Goldstein H; Pettoello-Mantovani M; Katopodis NF; Kim A; Yurasov S; Kollmann TR
    Semin Immunol; 1996 Aug; 8(4):223-31. PubMed ID: 8883145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for human immunodeficiency virus infection in the humanized SCID mouse model.
    Touraine JL; Sanhadji K; Sembeil R
    Isr Med Assoc J; 2003 Dec; 5(12):863-7. PubMed ID: 14689754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SCID-hu mouse as a model for HIV-1 infection.
    Aldrovandi GM; Feuer G; Gao L; Jamieson B; Kristeva M; Chen IS; Zack JA
    Nature; 1993 Jun; 363(6431):732-6. PubMed ID: 8515816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary HIV-1 infection of human CD4+ T cells passaged into SCID mice leads to selection of chronically infected cells through a massive fas-mediated autocrine suicide of uninfected cells.
    Parlato S; Santini SM; Lapenta C; Spada M; Logozzi M; Rizza P; Proietti E; Belardelli F; Fais S
    Cell Death Differ; 2000 Jan; 7(1):37-47. PubMed ID: 10713719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
    Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine interferon-beta synthesis for gene therapy of HIV infection: increased resistance to HIV-1 in lymphocytes from healthy and HIV-infected individuals.
    Vieillard V; Lauret E; Maguer V; Jacomet C; Rozenbaum W; Gazzolo L; De Maeyer E
    AIDS; 1995 Nov; 9(11):1221-8. PubMed ID: 8561974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice.
    Kollmann TR; Kim A; Pettoello-Mantovani M; Hachamovitch M; Rubinstein A; Goldstein MM; Goldstein H
    J Immunol; 1995 Jan; 154(2):907-21. PubMed ID: 7814892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines.
    Van Kuyk R; Mosier DE
    Virology; 1995 Jun; 209(2):643-8. PubMed ID: 7778296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis.
    Sundell IB; Halder R; Zhang M; Maricic I; Koka PS; Kumar V
    J Stem Cells; 2010; 5(1):33-42. PubMed ID: 20861926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro and in vivo inhibition of HIV1 replication by retroviral transfer of interferon alpha, beta, or gamma genes: application to gene therapy of AIDS].
    Leissner P; Calenda V; Marigliano M; Sanhadji K; Touraine JL; Pavirani A; Mehtali M
    Ann Biol Clin (Paris); 1998; 56(2):167-73. PubMed ID: 9754242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model.
    Nakata H; Maeda K; Miyakawa T; Shibayama S; Matsuo M; Takaoka Y; Ito M; Koyanagi Y; Mitsuya H
    J Virol; 2005 Feb; 79(4):2087-96. PubMed ID: 15681411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.